Claudio Pallavicini

Claudio Pallavicini is a neuroscientist whose work bridges cognitive neuroscience, neuroimaging and experimental psychopharmacology in the contemporary resurgence of psychedelic research. He has contributed to multimodal studies that probe acute brain dynamics under short‑acting tryptamines (notably DMT) using combined EEG–fMRI, and to experimental and epidemiological investigations of psilocybin (including controlled microdosing trials and studies of aesthetic perception under psilocybin). His publications span laboratory neuroimaging, behavioural and subjective outcome measures, and pandemic‑era population analyses examining associations between lifetime psychedelic use and mental‑health indicators.

Pallavicini’s research emphasis is on characterising the neural correlates of altered conscious states and on rigorous, controlled assessment of behavioural and cognitive effects of low‑dose and full‑dose psychedelic exposures. He has collaborated with multidisciplinary teams to integrate neurophysiological metrics (EEG/fMRI), psychometrics and experimental paradigms (e.g., gaze/fixation dynamics during visual aesthetic tasks), contributing data and analysis that inform mechanistic models of how serotonergic and other receptor systems modulate perception, cognition and emotion in psychedelic states.